Search

Search Constraints

You searched for: Author/Creator Remus, Kerstin

Search Results

1. DREAM5: An open‐label, randomized, cross‐over study to evaluate the safety and efficacy of day and night closed‐loop control by comparing the MD‐Logic automated insulin delivery system to sensor augmented pump therapy in patients with type 1 diabetes at home. Issue 4 (21st December 2018)

2. Insulin degludec's ultra‐long pharmacokinetic properties observed in adults are retained in children and adolescents with type 1 diabetes. Issue 1 (February 2014)

3. In‐home use of a hybrid closed loop achieves time‐in‐range targets in preschoolers and school children: Results from a randomized, controlled, crossover trial. Issue 7 (20th April 2022)

4. Lipoatrophy in children, adolescents and adults with insulin pump treatment: Is there a beneficial effect of insulin glulisine?. Issue 7 (19th August 2020)

5. Pharmacokinetic and prandial pharmacodynamic properties of insulin degludec/insulin aspart in children, adolescents, and adults with type 1 diabetes. Issue 8 (18th January 2016)

6. Reduced Worries of Hypoglycaemia, High Satisfaction, and Increased Perceived Ease of Use after Experiencing Four Nights of MD-Logic Artificial Pancreas at Home (DREAM4). (25th October 2015)